HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival
Pratistha Koirala(Fox Chase Cancer Center), Richard Görlick(The University of Texas MD Anderson Cancer Center), Jonathan Gill(Albert Einstein College of Medicine), Michael Roth(The University of Texas MD Anderson Cancer Center), Yekaterina V. Fatakhova(Manhattan University), David S. Geller(Albert Einstein College of Medicine), Michelle Ewart(Albert Einstein College of Medicine), Sajida Piperdi(Albert Einstein College of Medicine), Maya Ghorpade(Albert Einstein College of Medicine), Xingxing Zang(Albert Einstein College of Medicine), Bang H. Hoang(Albert Einstein College of Medicine), Jordan M. Chinai(Albert Einstein College of Medicine)
Cited by 106
Related Papers
K <sup>+</sup> Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension
|Science|2011|983
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
|European Journal of Cancer|2019|724
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
|The Lancet Oncology|2016|537
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
|Journal of Clinical Oncology|2015|419
Immune infiltration and PD-L1 expression in the tumor microenvironment are prognostic in osteosarcoma
|Scientific Reports|2016|263